Navigation Links
Synthetic biology key in the 21st century
Date:12/18/2008

Washington, DC Among the 75 people Esquire magazine recently chose as the most influential in the 21st century are three researchers in an emerging discipline that combines science and engineering in order to design and build novel biological functions and systems otherwise known as synthetic biology.

The promise of this burgeoning scientific field lies in the potential to apply engineering principles to the fundamental components of biology. This includes the design and construction of new biological parts, devices, and systems (e.g., tumor-seeking microbes for cancer treatment), as well as the re-design of existing, natural biological systems for useful purposes (e.g., plants making energy).

"Humans have been altering the genetic code of plants and animals for millennia, by selectively breeding individuals with desirable features. But more recent advances have enabled scientists to make new sequences of DNA from scratch. By combining these advances with the principles of modern engineering, scientists can now use computers and laboratory chemicals to design organisms that do new things -- like produce biofuels or excrete the precursors of medical drugs," says David Rejeski, the director of the Project.

But just how much about this field is covered in the media? And while these scientists featured in Esquire Drew Endy, Jay Keasling and Craig Venter may hold the keys to improved medial treatments and cleaner fuels, are there adequate controls and security measures to limit potential risks? The development of www.synbioproject.org marks an effort to answer those questions.

To provide a snapshot of the work to come, the Synthetic Biology Project announces the release of the landmark paper Trends in American and European Press Coverage of Synthetic Biology, which examines coverage of the field in recent years, as well as a quiz that tests your knowledge of synthetic biology.


'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Page: 1

Related biology news :

1. Synthetic biology: Is ethics a showstopper?
2. Synthetic virus supports a bat origin for SARS
3. UNC scientists teach enzyme to make synthetic heparin in more varieties
4. Biosynthetics production with detours
5. Synthetic Biology: Coming Up Fast!
6. Caltech engineers build firast-ever multi-input plug-and-play synthetic RNA device
7. New synthetic form of protein holds promise to stop cancer spread
8. Synthetic moleculues could add spice to fight against cancer
9. Synthetic molecules emulate enzyme behavior for the first time
10. Synthetic cocoa chemical slows growth of tumors in human cell lines
11. Synthetic Biology: funders move to address social and ethical challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... , March 2, 2017 Who risk to ... Download the full report: https://www.reportbuyer.com/product/4313699/ ... FINGERPRINT SENSOR FIELD? Fingerprint sensors using capacitive technology ... fingerprint sensor vendor Idex forecasts an increase of 360% ... devices and of the fingerprint sensor market between 2014 ...
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , a ... globally, announces significant enhancements to new and core technologies ... New products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity ... technology provides the fastest and most accurate capture software ...
(Date:2/27/2017)...   Strategic Cyber Ventures , the industry,s first ... $3.5 million investment in  Polarity , the first commercial ... DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran and ... series A round of funding. This new funding will ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... MILFORD, Mass. , March 23, 2017 ... leading partner to global in vitro diagnostics ... launch of the industry,s first multiplexed ... inherited disease testing by next-generation sequencing ... materials were developed with input from industry ...
(Date:3/23/2017)... , March 23, 2017 Kineta, Inc., ... of novel therapies in immuno-oncology, today announced the ... small molecule compounds that activate interferon response factor ... and demonstrate immune-mediated tumor regression in a murine ... study who demonstrated complete tumor regression to initial ...
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
(Date:3/22/2017)... Denmark , March 22, 2017  Ascendis ... utilizes its innovative TransCon technology to address significant ... financial results for the full year ended December ... significant year for our company as we broadened ... a leading, integrated rare disease company with an ...
Breaking Biology Technology: